Mamata S Kamat1, Rudrayya S Puranik2, A Bhagavan Das Rai3, B R Patil4, Shankargouda Patil5. 1. Department of Oral Pathology and Microbiology, Bharati Vidyapeeth (Deemed to Be University) Dental College and Hospital, Miraj road, Sangli, 416416, India. 2. Department of Oral Pathology and Microbiology, PMNM Dental College & Hospital, Nava Nagar, Bagalkote, Karnataka, 587103, India. 3. Department of Oral and Maxillofacial Surgery, Pacific Dental College and Hospital, Udaipur, 313024, India. 4. Consultant Surgical Oncologist, Karnataka Cancer Therapy and Research Institute, Navanagar, Hubli, 580025, India. 5. Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, 45142, Saudi Arabia. dr.ravipatil@gmail.com.
Abstract
OBJECTIVE: To assess and compare the immuno-expression of p53 and TP 53 gene amplification and correlate local recurrence and survival in histologically negative surgical margins of oral squamous cell carcinoma (OSCC) with normal oral mucosa. METHODS: Forty formalin-fixed paraffin-embedded tissue blocks of HNMs of OSCC and 40 normal oral mucosa samples were analyzed for p53 immunostaining and TP 53 gene amplification by PCR. RESULTS: Significantly, higher positivity was noted with p53 immuno-expression, TP53 gene amplification, and combined p53 and TP53 expression in the study group compared to the control group (C0.05). Most cases that were positive for p53 immuno-expression, TP 53 gene amplification, and combined p53 and TP53 expression showed local recurrence and poor survival. Kaplan-Meier survival analysis showed that subjects with TP53 and combined p53 and TP53 positivity had decreased survival rate than their negative counterparts. CONCLUSION: Detection of p53 in HNMs of OSCC can be used as a biomarker to identify patients at a higher risk of developing local recurrence and to predict survival. CLINICAL RELEVANCE: Combined p53 and TP 53 assessment may be more reliable for predicting LR to help clinicians and surgeons in treatment planning.
OBJECTIVE: To assess and compare the immuno-expression of p53 and TP 53 gene amplification and correlate local recurrence and survival in histologically negative surgical margins of oral squamous cell carcinoma (OSCC) with normal oral mucosa. METHODS: Forty formalin-fixed paraffin-embedded tissue blocks of HNMs of OSCC and 40 normal oral mucosa samples were analyzed for p53 immunostaining and TP 53 gene amplification by PCR. RESULTS: Significantly, higher positivity was noted with p53 immuno-expression, TP53 gene amplification, and combined p53 and TP53 expression in the study group compared to the control group (C0.05). Most cases that were positive for p53 immuno-expression, TP 53 gene amplification, and combined p53 and TP53 expression showed local recurrence and poor survival. Kaplan-Meier survival analysis showed that subjects with TP53 and combined p53 and TP53 positivity had decreased survival rate than their negative counterparts. CONCLUSION: Detection of p53 in HNMs of OSCC can be used as a biomarker to identify patients at a higher risk of developing local recurrence and to predict survival. CLINICAL RELEVANCE: Combined p53 and TP 53 assessment may be more reliable for predicting LR to help clinicians and surgeons in treatment planning.
Authors: Ana Carolina de Carvalho; Luiz Paulo Kowalski; Antônio Hugo José Fróes Marques Campos; Fernando Augusto Soares; André Lopes Carvalho; André Luiz Vettore Journal: Oral Oncol Date: 2011-11-21 Impact factor: 5.337
Authors: Punnya V Angadi; Prakash V Patil; Kaveri Hallikeri; M D Mallapur; Seema Hallikerimath; Alka D Kale Journal: Int J Surg Pathol Date: 2015-01-05 Impact factor: 1.271
Authors: Viola M M van Houten; C René Leemans; J Alain Kummer; Janny Dijkstra; Dirk J Kuik; Michiel W M van den Brekel; Gordon B Snow; Ruud H Brakenhoff Journal: Clin Cancer Res Date: 2004-06-01 Impact factor: 12.531
Authors: D B Jelovac; Z Tepavčević; N Nikolić; B Ilić; N Eljabo; B Popović; J Čarkić; V Konstantinović; M Vukadinović; B Miličić; J Milašin Journal: Int J Oral Maxillofac Surg Date: 2015-12-18 Impact factor: 2.789
Authors: Michael M Li; Sidharth V Puram; Dustin A Silverman; Matthew O Old; James W Rocco; Stephen Y Kang Journal: Ann Surg Oncol Date: 2019-08-05 Impact factor: 5.344
Authors: Anders Bilde; Christian von Buchwald; Erik Dabelsteen; Marianne Hamilton Therkildsen; Sally Dabelsteen Journal: J Oral Pathol Med Date: 2009-01 Impact factor: 4.253